Eric Winer, MD
Yale Cancer Center’s Annual Conclave, held on January 5, recognized the scientific and clinical accomplishments of the Center’s faculty and staff in 2022. Eric Winer, MD, hosted the event and presented research awards in four categories:
The Yale Cancer Center Population Science Research Prizes were presented to Michael S. Leapman, MD, MHS, Associate Professor of Urology and Clinical Program Leader, Prostate & Urologic Cancers Program, and Sajid Khan, MD, FACS, FSSO, Associate Professor of Surgery (Surgical Oncology) and Section Chief, Hepato-Pancreato-Biliary and Mixed Tumors. Dr. Leapman was given his award for his work on the study “Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer,” and Dr. Khan for “Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery,” both published in JAMA Open Network.
The Yale Cancer Center Translational Science Research Prize was presented to Rachel Perry, PhD, Assistant Professor of Cellular & Molecular Physiology and of Medicine (Endocrinology), for her papers in Precision Oncology: “Multimodal Analysis Suggests Differential Immuno-metabolic Crosstalk in Lung Squamous Cell Carcinoma and Adenocarcinoma” and Communications Biology, “A Precision Medicine Approach to Metabolic Therapy for Breast Cancer in Mice.”
The Yale Cancer Center Clinical Science Research Prize was awarded to Joseph Kim, MD, Associate Professor of Medicine (Medical Oncology) and Director of Prostate Cancer Research, for his publication in the Journal of Clinical Oncology: “Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.”
The Yale Cancer Center Basic Science Research Prizes were presented to Joseph Craft, MD, Paul B. Beeson Professor of Medicine (Rheumatology) and Professor of Immunobiology, and Nikhil Joshi, PhD, Associate Professor of Immunobiology, for their publication in Cell: “Neoantigen-Driven B Cell and CD4 T Follicular Helper Cell Collaboration Promotes Anti-tumor CD8 T Cell Responses.”